Burgess Paul D. bought KLRA
April 16, 2026 · Form 4 insider transaction
Burgess Paul D. bought 100,000 shares of Kailera Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
100,000
Price
$0.00
Total value
N/A
InsiderBurgess Paul D.
RoleOfficer
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateApril 16, 2026
Filing dateApril 20, 2026
Shares owned after100,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options vest and become exercisable as to 25% of the underlying shares on April 16, 2027 and thereafter in 36 substantially equal monthly installments, subject to the Reporting Person's continued service through each such vesting date.